期刊
JOURNAL OF PATHOLOGY
卷 216, 期 3, 页码 307-316出版社
WILEY
DOI: 10.1002/path.2413
关键词
molecular copy-number counting; cancer genomics; formalin-fixed paraffin-embedded; laser capture microdissection; lung cancer
资金
- UK Medical Research Council
- Rosetrees Trust
- MRC [MC_U105131672, G0600914, G0500392, MC_U105178807] Funding Source: UKRI
- Medical Research Council [MC_U105178807, G0500392, MC_U105131672, G0600914] Funding Source: researchfish
Most cancer genomes are characterized by the gain or loss of copies of some sequences through deletion, amplification or unbalanced translocations. Delineating and quantifying these changes is important in understanding the initiation and progression of cancer, in identifying novel therapeutic targets, and in the diagnosis and prognosis of individual patients. Conventional methods for measuring copy-number are limited in their ability to dynamic range ai analyse large numbers of loci, in their dynamic accuracy, or in their ability to analyse small or degraded samples. This latter limitation makes it difficult to access the wealth of fixed, archived material present in clinical collections, and also impairs our ability to analyse small numbers of selected cells from biopsies. Molecular copy-number counting (MCC), a digital PCR technique, has been used to delineate a non-reciprocal translocation using good quality DNA from a renal carcinoma cell line. We now demonstrate mu MCC, an adaptation of MCC which allows the precise assessment of copy number variation over a significant dynamic range, in template DNA extracted from formalin-fixed paraffin-embedded clinical biopsies. Further, mu MCC can accurately measure copy number variation at multiple loci, even when applied to picogram quantities of grossly degraded DNA extracted after laser capture microdissection of fixed specimens. Finally, we demonstrate the power of mu MCC to precisely interrogate cancer genomes, in a way, not currently feasible with other methodologies, by defining the position of a junction between an amplified and non-amplified genomic segment in a bronchial carcinoma. This has tremendous potential for the exploitation of archived resources for high-resolution targeted cancer genomics and in the future for interrogating multiple loci in cancer diagnostics or prognostics. Copyright (C) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据